Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Letter
  • Published:

Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: study in Bartter's/Gitelman's syndromes and relevance for hypertension

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Malik AR, Sultan S, Turner ST, Kullo IJ . Urinary albumin excretion is associated with impaired flow- and nitroglycerin-mediated brachial artery dilatation in hypertensive adults. J Hum Hypertens 2007; 21: 231–238.

    Article  CAS  Google Scholar 

  2. Cottone S, Mulè G, Nardi E, Lorito MC, Guarneri M, Arsena R et al. Microalbuminuria and early endothelial activation in essential hypertension. J Hum Hypertens 2007; 21: 167–172.

    Article  CAS  Google Scholar 

  3. Calò LA, Pessina AC, Semplicini A . Angiotensin II signaling in the Bartter's and Gitelman's syndromes, a negative human model of hypertension. High Blood Press Cardiovasc Prev 2005; 12: 17–26.

    Article  Google Scholar 

  4. Calò LA . Vascular tone control in humans: the utility of studies in Bartter's/Gitelman's syndromes. Kidney Int 2006; 69: 963–966.

    Article  Google Scholar 

  5. Calò LA, Pessina AC . RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans. J Hypertens 2007; 25: 259–264.

    Article  Google Scholar 

  6. Verdecchia P, Reboldi GP . Hypertension and microalbuminuria: the new detrimental duo. Blood Press 2004; 13: 198–211.

    Article  CAS  Google Scholar 

  7. Karalliedde J, Viberti G . Microalbuminuria and cardiovascular risk. Am J Hypertens 2004; 17: 986–993.

    Article  CAS  Google Scholar 

  8. Das UN . Is angiotensin II an endogenous pro-inflammatory molecule? Med Sci Monit 2005; 11: 155–162.

    Google Scholar 

  9. Touyz RM . Role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 2003; 5: 155–164.

    Article  Google Scholar 

  10. Calo L, Davis PA, Milani M, Cantaro S, Antonello A, Favaro S et al. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity. Clin Nephrol 1999; 51: 12–17.

    CAS  PubMed  Google Scholar 

  11. Davis PA, Mussap M, Pagnin E, Bertipaglia L, Savica V, Semplicini A et al. Early markers of inflammation in a high angiotensin II state. Results of studies in Bartter's/Gitelman's syndromes. Nephrol Dial Transpl 2006; 21: 1697–1701.

    Article  CAS  Google Scholar 

  12. Davis PA, Pagnin E, Semplicini A, Avogaro A, Calò LA . Insulin signaling, glucose metabolism and the angiotensin II signaling system. Studies in Bartter's/Gitelman's syndromes. Diabetes Care 2006; 29: 469–471.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L A Calò.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calò, L., Davis, P., Palatini, P. et al. Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: study in Bartter's/Gitelman's syndromes and relevance for hypertension. J Hum Hypertens 21, 904–906 (2007). https://doi.org/10.1038/sj.jhh.1002231

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002231

This article is cited by

Search

Quick links